2020 Volume 40 Issue 1 Pages 23-27
Previous studies have demonstrated that sugammadex can provide a reliable neuromuscular recovery from rocuronium-induced neuromuscular blockade(NMB)in patients with myasthenia gravis(MG). We divided MG patients undergoing extended thymectomy into two groups based on reversal of NMB with sugammadex(S group, n=31)or no reversal of NMB(C group, n=15)and retrospectively compared their need for postoperative mechanical ventilation in the intensive care unit. More patients in the S group received rocuronium than patients in the C group(p=0.011). The number of patients requiring postoperative mechanical ventilation in the intensive care unit was not significantly different between the two groups(6 cases in the S group vs. 4 cases in the C group).